Scale-Down Models for Microbial and Mammalian Cell Culture Processes
Ravali Raju, Jin Song Guo, Tatenda Shopera, Xiaolu Zheng, Jennifer Pulkowski, Nichole Wood
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
In the recent years, regulatory guidance has evolved to adopt a risk-based approach towards pharmaceutical manufacturing, which emphasizes that quality should be built into a process by design, leveraging development and manufacturing experience. The process validation guidance aligns activities with a product lifecycle concept occurring over three different stages of process design, process qualification, and continued process verification. This chapter discusses the application of scale-down models throughout the product life cycle to enable the design of robust processes and ensure safety, efficacy, and consistent product quality during commercial manufacturing. The key unit operations for both mammalian and microbial processes are discussed along with the general scale-down principles and parameters for each stage. Additionally, several case studies and examples are provided to demonstrate the development and application of scale-down models through the course of process development, validation, and commercial manufacturing.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Viral Infectious Diseases and Gene Expression in Insects
Protein purification and stability · Fluid Dynamics and Mixing